123 related articles for article (PubMed ID: 2614087)
1. CA 15.3 behaviour in cystic breast disease.
Vizoso F; Allende MT; Fueyo A; Vigal G; García-Morán M; Ruibal A
Int J Biol Markers; 1989; 4(3):181-2. PubMed ID: 2614087
[No Abstract] [Full Text] [Related]
2. Adrenal steroids and tumor antigens in plasma and cyst fluid of women with gross cystic breast disease.
Inaudi P; De Leo V; Baldini S; D'Antona N
Ann N Y Acad Sci; 1990; 586():117-20. PubMed ID: 2356994
[No Abstract] [Full Text] [Related]
3. Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease.
Allende MT; Vizoso F; Roiz MC; Fueyo A; Ruibal A
Int J Biol Markers; 1990; 5(1):48-9. PubMed ID: 2230352
[No Abstract] [Full Text] [Related]
4. [Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast].
Vizoso F; Roiz MC; Allende MT; Ruibal A
Med Clin (Barc); 1990 Mar; 94(8):319. PubMed ID: 2342398
[No Abstract] [Full Text] [Related]
5. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
Yenisey C; Güner G
Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
[No Abstract] [Full Text] [Related]
6. Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.
Vizoso F; Allende MT; Fueyo A; Riera L; López Otin C; Ruibal A
Int J Biol Markers; 1991; 6(1):31-2. PubMed ID: 1906915
[No Abstract] [Full Text] [Related]
7. [Correlations of serum concentrations of CA 15.3 and estradiol in women with breast macrocystic disease].
Vizoso F; Allende MT; Fueyo A; Vivanco J
Med Clin (Barc); 1990 May; 94(20):798. PubMed ID: 2392013
[No Abstract] [Full Text] [Related]
8. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
9. High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic disease.
Vizoso F; Allende MT; Fernàndez R; Suarez B; Diez MC; Ruibal A
Int J Biol Markers; 1991; 6(3):197-8. PubMed ID: 1791315
[No Abstract] [Full Text] [Related]
10. [Correlation between blood concentrations of CA 15.3 and estradiol in women with macrocystic disease of breast. Study in function of the type of cyst].
Vizoso F; Allende MT; Díez MC; Ruibal A
Rev Clin Esp; 1991 Nov; 189(8):390-1. PubMed ID: 1784805
[No Abstract] [Full Text] [Related]
11. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.
Vizoso F; Allende MT; Diez MC; Ruibal A
Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515
[No Abstract] [Full Text] [Related]
12. [The correlation between the serum concentrations of BCM (breast cancer mucin), CA549 and estradiol in women with breast macrocysts].
Vizoso F; Allende MT; Fueyo A; Ruibal A
Med Clin (Barc); 1991 Feb; 96(5):198. PubMed ID: 2033998
[No Abstract] [Full Text] [Related]
13. [The correlation between the serum concentrations of CA 549 and CA 15.3 in patients with cystic breast disease].
Allende MT; Vizoso F; Fueyo A; Ruibal A
Rev Clin Esp; 1990; 187(3):152-3. PubMed ID: 2284494
[No Abstract] [Full Text] [Related]
14. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
[TBL] [Abstract][Full Text] [Related]
15. Biochemical classification of patients with gross cystic breast disease.
Bradlow HL; Fleisher M; Breed CN; Chasalow FI
Ann N Y Acad Sci; 1990; 586():12-6. PubMed ID: 2192631
[No Abstract] [Full Text] [Related]
16. Analytical performance of CA 19.9, CA 125 and CA 15.3 assays as observed through an external quality assessment program.
Zucchelli GC; Pilo A; Chiesa MR; Masini S; Clerico A
Int J Biol Markers; 1994; 9(1):43-7. PubMed ID: 8051434
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease.
Lindhorst E
Tumour Biol; 2000; 21(2):116-22. PubMed ID: 10686541
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S
Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406
[TBL] [Abstract][Full Text] [Related]
19. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
[TBL] [Abstract][Full Text] [Related]
20. A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer.
de Wit R; Hoek FJ; Bakker PJ; Veenhof CH
Ann Oncol; 1992 Apr; 3(4):314-5. PubMed ID: 1390307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
